MedTrace Logo

Oxytocin Administration in the Third Stage of Labour - A Study of Appropriate Route and Dose

NCT00200252 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2012-11-09

No results posted yet for this study

Summary

Mothers are given the medication oxytocin after birth to help the uterus (womb) contract and therefore reduce blood loss. In Canada, oxytocin is given either into the muscle of the thigh or into a vein. However, it is not known which route is better.This study will test which dose and route of oxytocin is best in reducing blood loss following vaginal delivery.

Conditions

  • Third Stage of Labour

Interventions

DRUG

oxytocin

Sponsors & Collaborators

  • Memorial University of Newfoundland

    lead OTHER

Principal Investigators

  • Colleen L Cook, MD · Resident, Discipline Obstetrics and Gynecology, Memorial University of Newfoundland

  • Joan Crane, MD · Faculty, Discipline Obstetrics and Gynecolgy, Memorial University of Newfoundland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Completion
2007-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00200252 on ClinicalTrials.gov